SCHEMBL2587023

SCHEMBL2587023

CC(C)(C)OC(=O)C1C(=O)c2cc(F)ccc2OC12CCNCC2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.36
HTR2C P28335 2/20 0.35
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
AKR1B1 P15121 1/20 0.32
CYP19A1 P11511 1/20 0.32
FABP6 P51161 1/20 0.32
MAPK1 P28482 1/20 0.32
HDAC3 O15379 3/20 0.32
HDAC4 P56524 3/20 0.32
HDAC1 Q13547 3/20 0.32
HDAC7 Q8WUI4 3/20 0.32
HDAC2 Q92769 3/20 0.32
HDAC10 Q969S8 3/20 0.32
HDAC11 Q96DB2 3/20 0.32
HDAC8 Q9BY41 3/20 0.32
HDAC6 Q9UBN7 3/20 0.32
HDAC9 Q9UKV0 3/20 0.32
HDAC5 Q9UQL6 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2594195 0.92 HTR2C (0.35) MAPTHTR2CMAPK1HDAC3HDAC4
SCHEMBL18153814 0.88 PBRM1 (0.34) MAPTHTR2CKDM4ECYP19A1MAPK1
SCHEMBL3836335 0.87 OPRD1 (0.36) ALDH1A1MAPK1HDAC3HDAC4HDAC1
SCHEMBL2591939 0.85 OPRD1 (0.39) MAPK1
SCHEMBL5291744 0.84 CYP1A2 (0.36) MAPTHTR2CKDM4EALDH1A1HDAC3
SCHEMBL3842494 0.81 MAPK1 (0.32) MAPK1
SCHEMBL14919110 0.79 MAPT (0.42) MAPTHTR2CAKR1B1CYP19A1FABP6
SCHEMBL1567927 0.78 CYP11B2 (0.37)
SCHEMBL14972882 0.70 HTR2C (0.40) MAPTHTR2CAKR1B1CYP19A1FABP6
SCHEMBL21397469 0.70 DPP4 (0.37) HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2595989-A1 HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Incorporated (US) 2013-05-29 EP disclosed
WO-2011140425-A1 HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-11-10 WO disclosed